Howard Hughes Medical Institute
In its 13F for Q1 2025 (holdings as of March 31, 2025, filed May 15, 2025), Howard Hughes Medical Institute reported 2 stock positions worth $202.2 million. Its top holding was SS SPDR S&P 500 ETF Trust-US (SPY) at 99.8% of the portfolio, followed by Bioage Labs (BIOA, 0.2%). Compared with Q4 2024, it reduced 1. The biggest sale was SS SPDR S&P 500 ETF Trust-US (SPY, shares −63%).
- Most Recent 13F
- Q2 2026
- Location
- Chevy Chase, MD
- CIK
- 0000810386
- Portfolio Value
- $202.2M (Q1 2025)
- SEC Filing
- 0000950123-25-005367 ↗ filed May 15, 2025
Holdings Value
Holdings 2 stocks · $202.2M
Portfolio Sells Q4 2024 → Q1 2025
| SPY SS SPDR S&P 500 ETF Trust-US | Reduce -62.8% | 99.79% | −0.10 |
Portfolio Buys Q4 2024 → Q1 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 30 | $445.4M | NVDA, AAPL, GOOGL, MSFT, TSM |
| Q1 2026 | 31 | $415.8M | SPY, NVDA, AAPL, GOOGL, MSFT |
| Q4 2025 | 500 | $174.7M | SPY, NVDA, AAPL, MSFT, AMZN |
| Q3 2025 | 500 | $170.6M | SPY, NVDA, MSFT, AAPL, AMZN |
| Q2 2025 | 501 | $250.9M | SPY, NVDA, MSFT, AAPL, AMZN |
| Q1 2025 | 2 | $202.2M | SPY, BIOA |
| Q4 2024 | 2 | $568.4M | SPY, BIOA |
| Q3 2024 | 2 | $630.4M | SPY, BIOA |
| Q2 2024 | 1 | $466.2M | SPY |
| Q1 2024 | 2 | $332.9M | SPY, PCT |